Home›Stock Screener›Trualt Bioenergy›Financial Statements

Trualt Bioenergy Complete Financial Statements

4 Years of Data
2026 - 2023

In FY2026, Trualt Bioenergy (TRUALT) reported revenue ₹627 Cr, net profit ₹61 Cr and EPS ₹6.99, with a net profit margin of 9.7% and ROE of 4.0%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review Trualt Bioenergy price earnings to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.73% 2026 data
EBITDA Margin 23.92% 2026 data
Operating Margin 20.00% 2026 data
Return on Assets 1.61% 2026 data
Return on Equity 4.01% 2026 data

Balance Sheet Ratios

Current Ratio 1.33 2026 data
Equity Ratio 40.23% 2026 data
Asset Turnover 0.17 2026 data

TRUALT Revenue, Net Profit & EBITDA — Year-on-Year Growth

TRUALT YoY (Mar 2025 vs Mar 2026) — revenue -31.9%, net profit -45.5%, EBITDA -10.2%, expenses -36.7%. Explore TRUALT fundamental worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
-31.9%
Year-over-Year
Net Profit Growth
-45.5%
Year-over-Year
EBITDA Growth
-10.2%
Year-over-Year
Expense Growth
-36.7%
Year-over-Year
Assets Growth
+24.7%
Year-over-Year
Equity Growth
+97.7%
Year-over-Year
Operating Cash Flow Growth
+813.9%
Year-over-Year
Investing Cash Flow Growth
+36.7%
Year-over-Year
Financing Cash Flow Growth
-89.1%
Year-over-Year

TRUALT Income Statement — Revenue, EBITDA & Net Profit

Trualt Bioenergy revenue ₹627 Cr, EBITDA ₹150 Cr, net profit ₹61 Cr, EPS ₹6.99 (2026) — net profit margin 9.7%. For live price, earnings ratios and company overview, see Trualt Bioenergy share price chart.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Jun 2024 Dec 2024
Revenue 627 130 921 327 731 405 213 431
Expenses 477 119 753 262 579 371 184 291
EBITDA 150 10 167 64 152 34 29 140
Operating Profit Margin % 20.00% -4.00% 17.00% 14.00% 19.00% 4.00% 7.00% 30.00%
Depreciation 23 21 18 21 22 16 16 18
Interest 44 39 39 38 40 34 35 36
Profit Before Tax 84 -49 111 6 90 -16 -22 86
Tax 23 -11 -1 1 21 2 0 11
Net Profit 61 -38 112 5 69 -19 -22 75
Earnings Per Share (₹) 6.99 -5.37 15.81 0.67 8.07 -2.64 -3.04 10.65

TRUALT Balance Sheet — Assets, Liabilities & Shareholders' Equity

TRUALT total assets ₹3,778 Cr, total equity ₹1,520 Cr, total liabilities ₹ Cr (2026) — ROE 4.0%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023
ASSETS
Total Assets 3,778 3,030 2,419 1,856
Current Assets 1,479 1,062 658 464
Fixed Assets 2,202 1,826 1,427 1,302
Capital Work in Progress 68 3 201 10
Investments 528 4 10 0
Other Assets 0 1,197 781 545
LIABILITIES
Total Liabilities
Current Liabilities 1,115 1,213 1,093 1,173
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,520 769 265 241
Share Capital 86 71 61 61
Reserves & Surplus 1,435 698 57 33

TRUALT Cash Flow Statement — Operating, Investing & Financing

Trualt Bioenergy operating cash flow ₹329 Cr, investing ₹-243 Cr, financing ₹40 Cr, net cash flow ₹126 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 329 36 234
Investing Activities -243 -384 -1,149
Financing Activities 40 367 920
Net Cash Flow 126 19 5